Atrion Reports Second Quarter 2024 Results
Rhea-AI Summary
Atrion (NASDAQ: ATRI) reported its Q2 2024 results, showing revenue growth of 11% to $48.8 million. However, operating income decreased significantly to $0.5 million, largely due to a $5.0 million accrual for acquisition-related expenses. Excluding this accrual, adjusted operating income was $5.5 million, down 25% year-over-year. Diluted EPS fell to $0.23 from $3.73 in Q2 2023.
The company saw strong growth in MPS consoles (22%) and disposables (21%), along with recovery in fluid delivery products. Atrion continued to reduce inventories, which negatively impacted operating income but resulted in an 18% inventory reduction since December 31, 2023. As of June 30, 2024, Atrion remained debt-free with $23.2 million in cash and investments.
Positive
- Revenue growth of 11% to $48.8 million in Q2 2024
- MPS consoles sales up 22% and MPS disposables sales up 21%
- Recovery in fluid delivery products with double-digit revenue increases in certain product families
- 18% reduction in inventory levels since December 31, 2023
- Debt-free status maintained with $23.2 million in cash and investments
Negative
- Operating income decreased to $0.5 million from $7.4 million in Q2 2023
- Diluted EPS fell to $0.23 from $3.73 in Q2 2023
- Adjusted operating income (excluding merger accrual) down 25% year-over-year
- Halted production lines to reduce inventories, resulting in under-absorption of overhead
- $5.0 million accrual for acquisition-related expenses impacting operating income
News Market Reaction
On the day this news was published, ATRI gained 0.03%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024.
Revenues for the second quarter of 2024 totaled
Commenting on the results for the second quarter of 2024 compared to the prior year period, David Battat, President and CEO, stated, “We were pleased to see strong revenue growth of
Mr. Battat concluded, “As of June 30, 2024, cash and short- and long-term investments totaled
Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.
| Contact: | Cindy Ferguson Vice President and Chief Financial Officer (972) 390-9800 |
| ATRION CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Revenues | $ | 48,773 | $ | 43,838 | $ | 96,107 | $ | 83,831 | |||||||
| Cost of goods sold | 32,926 | 26,584 | 67,909 | 51,496 | |||||||||||
| Gross profit | 15,847 | 17,254 | 28,198 | 32,335 | |||||||||||
| Operating expenses | 15,313 | 9,875 | 24,522 | 20,486 | |||||||||||
| Operating income | 534 | 7,379 | 3,676 | 11,849 | |||||||||||
| Interest and dividend income | 388 | 127 | 544 | 367 | |||||||||||
| Other investment income (loss) | (542 | ) | 98 | (651 | ) | (623 | ) | ||||||||
| Other income | 23 | 29 | 37 | 39 | |||||||||||
| Interest expense | -- | (27 | ) | -- | (27 | ) | |||||||||
| Income before income taxes | 403 | 7,606 | 3,606 | 11,605 | |||||||||||
| Income tax provision | (1 | ) | (1,043 | ) | (412 | ) | (1,557 | ) | |||||||
| Net income | $ | 402 | $ | 6,563 | $ | 3,194 | $ | 10,048 | |||||||
| Income per basic share | $ | 0.23 | $ | 3.73 | $ | 1.81 | $ | 5.71 | |||||||
| Weighted average basic shares outstanding | 1,761 | 1,760 | 1,761 | 1,761 | |||||||||||
| Income per diluted share | $ | 0.23 | $ | 3.73 | $ | 1.81 | $ | 5.70 | |||||||
| Weighted average diluted shares outstanding | 1,763 | 1,761 | 1,762 | 1,762 | |||||||||||
| ATRION CORPORATION CONSOLIDATED BALANCE SHEETS (In thousands) | |||||
| June 30, | Dec 31, | ||||
| ASSETS | 2024 | 2023 | |||
| (Unaudited) | |||||
| Current assets: | |||||
| Cash and cash equivalents | $ | 11,462 | $ | 3,565 | |
| Short-term investments | 6,124 | 2,691 | |||
| Total cash and short-term investments | 17,586 | 6,256 | |||
| Accounts receivable | 26,555 | 23,029 | |||
| Inventories | 67,641 | 82,307 | |||
| Prepaid expenses and other | 7,480 | 3,173 | |||
| Total current assets | 119,262 | 114,765 | |||
Long-term investments | 5,624 | 8,165 | |||
Property, plant and equipment, net | 122,905 | 125,347 | |||
| Other assets | 12,563 | 12,548 | |||
| $ | 260,354 | $ | 260,825 | ||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||
| Current liabilities | 17,537 | 12,621 | |||
| Other non-current liabilities | 3,944 | 5,315 | |||
| Stockholders’ equity | 238,873 | 242,889 | |||
| $ | 260,354 | $ | 260,825 | ||
| ATRION CORPORATION NON-GAAP FINANCIAL INFORMATION (In thousands) |
This release includes a reference to non-GAAP operating income that excludes merger-related expenses accrued in the second quarter of 2024. This financial measure is not prepared in accordance with GAAP. The operating income excluding the merger accrual is calculated by increasing operating income by the amount of the merger-related expenses.
We believe that this non-GAAP measure provides insight into our operating income performance. However, this non-GAAP financial measure may not be comparable to similarly titled non-GAAP financial measures used by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for GAAP financial measures. and are supplemental to the comparable GAAP measures.
Reconciliation to the most directly comparable GAAP measure is provided in the table below.
| Three Months Ended June 30, | |||||||||
| 2024 | 2023 | Change | |||||||
| Revenues | $ | 48,773 | $ | 43,838 | 11 | % | |||
| Cost of goods sold | 32,926 | 26,584 | |||||||
| Gross profit | 15,847 | 17,254 | |||||||
| Operating income | 534 | 7,379 | |||||||
| Add: merger accrual | 5,000 | - | |||||||
| Operating income excluding merger accrual | 5,534 | 7,379 | (25 | %) | |||||